SVBP

Across TCGA pan-cancer cohorts, SVBP mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated SVBP data layer compared with 21 for mass-spec protein and 1 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher SVBP mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated SVBP expression acts as an unfavorable survival marker, although some lineages such as CCRCC and PDAC show a favorable association.

HNSC, LUAD, and CCRCC are the cancer types where SVBP mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Median	III,IV	0.682	0.897	.008	15	view →
LUAD	OS	Median	All	0.683	0.946	.024	4	view →
CCRCC	OS	Quartile	All	1.000	0.834	.031	2	view →
PDAC	OS	Median	II,III,IV	0.595	0.433	.027	2	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

SVBP–HNSC (DFS)

Open the HNSC breakdown →